blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3009843

EP3009843 - METHOD FOR DETERMINING DOSAGE OF ERYTHROPOIESIS-STIMULATING AGENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.10.2019
Database last updated on 24.07.2024
FormerExamination is in progress
Status updated on  02.02.2018
Most recent event   Tooltip18.10.2019Application deemed to be withdrawnpublished on 20.11.2019  [2019/47]
Applicant(s)For all designated states
Nipro Corporation
9-3 Honjo-nishi 3-chome Kita-ku
Osaka-shi, Osaka 531-8510 / JP
[2016/16]
Inventor(s)01 / SHINZATO, Toru
c/o NEXTIER CORPORATION
82-1 Aza
Karaike
Minamisakae-cho
Toyohashi-shi Aichi 441-8107 / JP
02 / MARUYAMA, Yasuyo
c/o NEXTIER CORPORATION
82-1 Aza
Karaike
Minamisakae-cho
Toyohashi-shi Aichi 441-8107 / JP
03 / UENO, Fumihiko
c/o NANO MEDICAL CORPORATION
1-4 Hacchobori 1-chome
Chuo-ku
Tokyo 104-0032 / JP
 [2016/16]
Representative(s)Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
[2016/16]
Application number, filing date14810587.712.06.2014
[2016/16]
WO2014JP65571
Priority number, dateJP2013012467613.06.2013         Original published format: JP 2013124676
[2016/16]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014200054
Date:18.12.2014
Language:JA
[2014/51]
Type: A1 Application with search report 
No.:EP3009843
Date:20.04.2016
Language:EN
[2016/16]
Search report(s)International search report - published on:JP18.12.2014
(Supplementary) European search report - dispatched on:EP03.01.2017
ClassificationIPC:G01N33/72, G16C20/30
[2019/14]
CPC:
G01N33/72 (EP,US); G01N33/721 (US); G16C20/30 (EP,US);
G16H20/10 (EP,US); G16H20/17 (US); G01N2333/805 (US)
Former IPC [2017/04]G06F19/00, G01N33/72
Former IPC [2016/16]G01N33/72
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/16]
TitleGerman:VERFAHREN ZUR BESTIMMUNG DER DOSIERUNG EINES ERYTHROPOIESESTIMULATORS[2016/16]
English:METHOD FOR DETERMINING DOSAGE OF ERYTHROPOIESIS-STIMULATING AGENT[2016/16]
French:PROCÉDÉ POUR DÉTERMINER LE DOSAGE D'UN AGENT DE STIMULATION DE L'ÉRYTHROPOÏÈSE[2016/16]
Entry into regional phase11.12.2015Translation filed 
23.12.2015National basic fee paid 
23.12.2015Search fee paid 
23.12.2015Designation fee(s) paid 
23.12.2015Examination fee paid 
Examination procedure23.12.2015Examination requested  [2016/16]
17.07.2017Amendment by applicant (claims and/or description)
02.02.2018Despatch of a communication from the examining division (Time limit: M04)
30.05.2018Reply to a communication from the examining division
29.08.2018Despatch of a communication from the examining division (Time limit: M02)
22.10.2018Reply to a communication from the examining division
08.04.2019Despatch of a communication from the examining division (Time limit: M02)
19.06.2019Application deemed to be withdrawn, date of legal effect  [2019/47]
16.07.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2019/47]
Fees paidRenewal fee
29.06.2016Renewal fee patent year 03
27.06.2017Renewal fee patent year 04
25.06.2018Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.06.201906   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2011116919  (FRESENIUS MEDICAL CARE DE GMBH [DE], et al) [I] 1-6 * the whole document *;
 [I]WO2013036836  (FRESENIUS MED CARE HLDG INC [US], et al) [I] 1-6 * the whole document *
International search[A]WO2011116919  (FRESENIUS MEDICAL CARE DE GMBH [DE], et al);
 [A]JP2005247858  (ORTHO MCNEIL PHARM INC);
 [A]  - YUZO WATANABE ET AL., "Hozonki Mansei Jinzobyo Kanja o Taisho to shita Hinketsu Kaizen Koka no Kento -KRN321-SC Shoki Dai II-so Shiken", KIDNEY AND DIALYSIS, (20100225), vol. 68, no. 2, pages 273 - 283, XP008181687
 [A]  - HIROKATSU ATSUMI ET AL., "Computer o Riyo shita Ketsueki Toseki Kanja ni Okeru Tetsu Oyobi Sekkekkyu Zoketsu Shigeki Inshi Seizai no Toyo- ryo Kettei Shien", JOURNAL OF KANAZAWA MEDICAL UNIVERSITY, (201112), vol. 36, no. 4, pages 119 - 123, XP008181684
 [A]  - DANA C. MISKULIN ET AL., "Computerized Decision Support for EPO Dosing in Hemodialysis Patients", AMERICAN JOURNAL OF KIDNEY DISEASES, (20091201), vol. 54, no. 6, doi:10.1053/J.AJKD.2009.07.010, pages 1081 - 1088, XP055301592

DOI:   http://dx.doi.org/10.1053/j.ajkd.2009.07.010
 [A]  - NOBUO NAGANO ET AL., "Shinsedai Hinketsu Chiryoyaku (KRN321, Darbepoetin Alfa) no Kiso Tokusei", KIDNEY AND DIALYSIS, (20060625), vol. 60, no. 6, pages 1039 - 1046, XP008181686
by applicant   - YANG W ET AL., J. AM. SOC. NEPHROL, (2007), vol. 18, pages 3164 - 3170
    - FISHBANE S ET AL., KIDNEY INT., (2005), vol. 68, pages 1337 - 1343
    - LINES SW ET AL., NEPHROL. DIAL. TRANSPLANT, (2012), vol. 27, pages 2425 - 2429
    - NOBURO NAGANO ET AL., KIDNEY AND HEMODIALYSIS, (2006), vol. 60, no. 6, pages 1039 - 1046
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.